Current Report Filing (8-k)
2019年9月28日 - 12:48AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of Report (Date of earliest event reported)
September 23,
2019
cbdMD, INC.
|
(Exact name of registrant as specified in its charter)
|
North Carolina
|
001-38299
|
47-3414576
|
(State or other jurisdiction of incorporation or
organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
8845 Red Oak Blvd, Charlotte, NC 28217
(Address of principal executive offices)(Zip Code)
Registrant's
telephone number, including area code: (704) 445-3060
________________________________
|
(Former name or former address, if changed since last
report)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
common
|
YCBD
|
NYSE
American
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this
chapter).
Emerging
growth company ☑
|
|
If an
emerging growth company, indicate by checkmark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange
Act. ☐
Item
7.01 Regulation
FD Disclosure.
On
September 27, 2019, cbdMD, Inc. issued a press release announcing
the advisory agreement with Hans Molenkamp. A copy of this press
release is furnished as Exhibit 99.1 to this report.
Pursuant
to General Instruction B.2 of Form 8-K, the information in this
Item 7.01 of Form 8-K, including Exhibit 99.1, is being furnished
and shall not be deemed “filed” for the purposes of
Section 18 of the Securities Exchange Act of 1934 or otherwise be
subject to the liabilities of that section, nor is it incorporated
by reference into any filing of cbdMD, Inc. under the Securities
Act of 1933 or the Securities Exchange Act of 1934, whether made
before or after the date hereof, regardless of any general
incorporation language in such filing.
Item
8.01 Other
Events.
On September 23, 2019, cbdMD, Inc., entered into a one-year
advisory agreement with Hans Molenkamp. Under the terms of the
agreement, Mr. Molenkamp will oversee certain athletes and
influencers with which cbdMD, Inc. has a relationship and provide
other advisory and consulting services to us related to developing
and facilitating sales and business strategies in our sports
marketing division. During his non-exclusive engagement with cbdMD
Inc., Mr. Molenkamp, who is an independent contractor for our
company, will hold the title of Vice President of Sports Marketing,
reporting to cbdMD’s co-CEO Scott Coffman, who will have
direction and control over the business strategies. The monthly fee
during the contract is $16,667 and after the initial term of the
engagement, the contract will be on a month to month basis unless
terminated by either party upon 30 days prior written notice to the
other party. The advisory agreement contains customary
confidentiality and ownership of intellectual property
provisions.
Item
9.01 Financial
Statements and Exhibits.
|
|
|
|
Incorporated by Reference
|
|
Filed or
Furnished
Herewith
|
No.
|
|
Exhibit Description
|
|
Form
|
|
Date Filed
|
|
Number
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Press
release dated September 27, 2019
|
|
|
|
|
|
|
|
Furnished
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
cbdMD,
Inc.
|
|
|
|
Date:
September 27, 2019
|
By:
|
/s/
Mark S. Elliott
|
|
|
Mark S.
Elliott, Chief Financial Officer and Chief Operating
Officer
|
Level Brands, Inc. (AMEX:LEVB)
過去 株価チャート
から 5 2024 まで 6 2024
Level Brands, Inc. (AMEX:LEVB)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Level Brands, Inc. (アメリカ証券取引所): 0 recent articles
その他のCbdmd, Inc.ニュース記事